| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.064 | 0.2 |